| P50 | author | Carolina Horta Andrade | Q20047953 |
| | Pedro Cravo | Q55175710 |
| | Vinicius Alves | Q56514156 |
| | Marilia N N Lima | Q88113670 |
| P2093 | author name string | Gustavo C Cassiano | |
| | Fabio T M Costa | |
| | Eugene N Muratov | |
| | Daniel Y Bargieri | |
| | Juliana Calit | |
| | Rodolpho C Braga | |
| | Cleber C Melo-Filho | |
| | Bruno J Neves | |
| P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| | β-Branched acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase | Q27666990 |
| | Design, synthesis, and evaluation of 5'-diphenyl nucleoside analogues as inhibitors of the Plasmodium falciparum dUTPase | Q27675357 |
| | Synthesis and Discovery of N-Carbonylpyrrolidine- or N-Sulfonylpyrrolidine-Containing Uracil Derivatives as Potent Human Deoxyuridine Triphosphatase Inhibitors | Q27677953 |
| | dUTP pyrophosphatase is an essential enzyme in Saccharomyces cerevisiae | Q27933078 |
| | The March Toward Malaria Vaccines | Q28084325 |
| | Human malaria parasites in continuous culture | Q28131626 |
| | QSAR modeling: where have you been? Where are you going to? | Q28222668 |
| | A comprehensive evaluation of rodent malaria parasite genomes and gene expression | Q28250679 |
| | Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 |
| | Best Practices for QSAR Model Development, Validation, and Exploitation | Q28649930 |
| | The dUTPase enzyme is essential in Mycobacterium smegmatis | Q28729224 |
| | Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research | Q28748220 |
| | Integrated Modeling Program, Applied Chemical Theory (IMPACT) | Q28751619 |
| | Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture | Q29547549 |
| | Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation | Q29617869 |
| | Computational methods in drug discovery. | Q30398071 |
| | FRED pose prediction and virtual screening accuracy | Q30399715 |
| | Comparison of Shape-Matching and Docking as Virtual Screening Tools | Q56853909 |
| | QSAR Modelling of Rat Acute Toxicity on the Basis of PASS Prediction | Q56973893 |
| | Acyclic Nucleoside Analogues as Inhibitors ofPlasmodiumfalciparumdUTPase | Q58848659 |
| | Introduction. dUTPases | Q78345629 |
| | Hierarchical QSAR technology based on the Simplex representation of molecular structure | Q80642889 |
| | Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules | Q81360455 |
| | 3D-QSAR illusions | Q81437679 |
| | Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database | Q30494222 |
| | Trust, but Verify II: A Practical Guide to Chemogenomics Data Curation | Q31106801 |
| | Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum | Q34086895 |
| | ADMET in silico modelling: towards prediction paradise? | Q35075770 |
| | Tuning HERG out: antitarget QSAR models for drug development | Q35164442 |
| | Pred-hERG: A Novel web-Accessible Computational Tool for Predicting Cardiac Toxicity | Q36095155 |
| | QSAR-Driven Discovery of Novel Chemical Scaffolds Active against Schistosoma mansoni | Q37616239 |
| | 3D-QSAR in drug design--a review | Q37636264 |
| | 3D-QSAR approaches in drug design: perspectives to generate reliable CoMFA models | Q38203930 |
| | QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity | Q38743096 |
| | Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles. | Q38832674 |
| | Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening | Q39300204 |
| | Combating multidrug-resistant Plasmodium falciparum malaria | Q39350422 |
| | Lethality of a dut (deoxyuridine triphosphatase) mutation in Escherichia coli | Q39952289 |
| | Deoxyuridine triphosphate nucleotidohydrolase as a potential antiparasitic drug target | Q40389210 |
| | admetSAR: a comprehensive source and free tool for assessment of chemical ADMET properties | Q42673952 |
| | Site-directed mutagenesis provides insights into the selective binding of trityl derivatives to Plasmodium falciparum dUTPase | Q43997028 |
| | Assessing transmission blockade in Plasmodium spp. | Q44165859 |
| | Curation of chemogenomics data | Q44858653 |
| | Exploring structural requirements for a class of nucleoside inhibitors (PfdUTPase) as antimalarials: first report on QSAR, pharmacophore mapping and multiple docking studies | Q45005607 |
| | dUTPase as a platform for antimalarial drug design: structural basis for the selectivity of a class of nucleoside inhibitors. | Q45255581 |
| | Design, synthesis and evaluation of novel uracil acetamide derivatives as potential inhibitors of Plasmodium falciparum dUTP nucleotidohydrolase. | Q46488809 |
| | Infectious diseases. The genetics of resistant malaria | Q47895033 |
| | Modified 5'-trityl nucleosides as inhibitors of Plasmodium falciparum dUTPase | Q47970171 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 146 | |
| P577 | publication date | 2018-03-06 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | QSAR-Driven Design and Discovery of Novel Compounds With Antiplasmodial and Transmission Blocking Activities | |
| P478 | volume | 9 | |